International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Aug 14, 2025, after the close
10-Q filed Aug 14, 2025, 45 days after period end · 0001193125-25-180761
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $2.45M | $2.33M | $1.84M | $2.03M |
| Net Income | $129.00K | $119.00K | $492.00K | -$2.00K |
| EPS Diluted | $0.01 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| $0.01 |
| $0.03 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
